Andrew Lieberman, MD, PhD, Gerald D. Abrams Collegiate Professor and Director of Neuropathology, has been elected to serve on the Neuropathology Core Steering Committee of the National Alzheimer’s Coordinating Center (NACC). The goal of the committee is to address shared issues pertaining to neuropathology that occur within 32 Alzheimer’s Disease Centers funded by the National Institutes of Health and to assist in coordinating center activities.
Located at medical centers across the U.S., including Michigan, these centers are designed to provide support to patients and their families and to spur research into age-related dementias including Alzheimer’s Disease and Lewy Body Dementia.
Dr. Lieberman’s research focuses on understanding the mechanisms underlying neurological dysfunction in inherited neurodegenerative diseases with the goal of developing effective treatments. He will serve on the NACC Neuropathology Core Steering Committee for a three-year term.